当前位置: 首页 > 期刊 > 《中国当代医药》 > 2019年第13期
编号:13380158
主动斑块转移技术在冠状动脉分叉病变中的运用(3)
http://www.100md.com 2019年5月5日 《中国当代医药》 2019年第13期
     [3]Medina A,Suarez de Lezo J,Pan M.A new classification of coronary bifurcation lesions[J].Rev Esp Cardiol,2006,59(2):183.

    [4]Finch W,Lee MS.Percutaneous coronary intervention coronary bifurcation lesions[J].Rev Cardiovasc Med,2017,18(2):59-66.

    [5]Stinis CT,Hu SP,Price MJ,et al.Three-year outcome of drugeluting stent implantation for coronary artery bifurcation lesions[J].Catheter Cardiovasc Interv,2010,75(3):309-314.

    [6]肖建強,高磊,唐如柯,等.冠状动脉真性分叉病变置入双支架及单支架的疗效比较[J].疑难病杂志,2017,16(3):993-996.

    [7]Vassilev D,Gil R.Clinical verification of a theory for predicting side branch stenosis after main vessel stenting in coronary bifurcation lesions[J].J Interv Cardiol,2008,21(6):493-503.

    [8]窦克非,张冬.冠状动脉分叉病变介入治疗中分支血管闭塞风险评估[J].心脑血管病防治,2015,15(5):353-355.

    [9]Hahn JY,Chun WJ,Kim JH,et al.Predictors and outcomes of side branch occlusion after main stenting in coronary bifurcation lesions results from the COBIS Ⅱregistry(Coronary Bifurcation Stenting)[J].J Am Coll Cardiol,2013,62(18):1654-1659.

    [10]Kang SJ,Mintz GS,Kim WJ,et al.Preintervention angiographic and intravascular ultrasound predictors for side branch compromise after a single-stent crossover technique[J].Am J Cardiol,2011,107(12):1787-1793.

    [11]杨吴翰,张冬,王昊,等.冠脉分叉病变主支血管支架置入术后分支闭塞的预测因素[J].中国分子心脏病学杂志,2015,(6):1516-1521.

    [12]Jeremis A,Kleiman NS,Nassif D,et al.Prevalence and prognostic signifcance of preprocedural cardiac tropon in elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention:results from the evaluation of drug eluting stents and ischemic events registry[J].Circulation,2008,118(6):632-638.

    [13]吴金斌,邹得学,周奎,等.高敏肌钙蛋白 T 和普通肌钙蛋白I在急性心肌梗死早期诊断中的临床应用价值[J].国际检验医学杂志,2016,37(13):1799-1803.

    [14]苏行,孙黎明,徐海涛,等.预留小球囊对冠状动脉分叉病变中分支的保护作用[J].中国综合临床,2015,31(3):220-222.

    [15]金国珍,王军,刘志忠,等.拘禁球囊技术在冠状动脉分叉病变中应用的临床疗效观察[J].中国心血管杂志,2017, 12(6):428-432.

    (收稿日期:2018-05-17 本文编辑:闫 佩), 百拇医药(胡铂 汪云开 王小东)
上一页1 2 3